CompletedNCT02901587
Official study titleInterventional, Randomised, Double-blind, Parallel-group, Active-control, Multiple-dose Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In Long BeachSchizophreniaMedication studyAges 21–60
- Countries
- United States
- Sponsor
- H. Lundbeck A/S
CompletedNCT00535145
Official study titleA Single-arm Evaluation of the Safety of Paliperidone Extended-Release (ER) in Subjects With Schizophrenia or Schizoaffective Disorder With Hepatic Disease
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosSchizophreniaMedication studyAges 18+
- Countries
- United States
- Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
CompletedNCT03571685
Official study titleA Prospective, Open Label, Quasi-Experimental Study of Adult Patients With Schizophrenia or Schizoaffective Disorder Within Five Years of Diagnosis Who Will Receive SEEC Intervention
This study has finished and is no longer accepting participants.
In San DiegoSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Janssen Scientific Affairs, LLC
CompletedNCT04013555
This study has finished and is no longer accepting participants.
In CatonsvilleSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
CompletedNCT00141479
What is this study about?This study evaluated the safety of Bifeprunox for people with schizophrenia.
This study has finished and is no longer accepting participants.
In WichitaSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Solvay Pharmaceuticals
CompletedNCT01423916
Official study titleA Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Long BeachSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00492349
This study has finished and is no longer accepting participants.
In BaltimoreSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
CompletedNCT00727103
Official study titleVarenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia - a Double Blind, Placebo Controlled Trial
This study has finished and is no longer accepting participants.
In SyracuseSchizophrenia, AddictionMedication studyAges 18–69
- Countries
- United States
- Sponsor
- State University of New York - Upstate Medical University
CompletedNCT04251195
This study has finished and is no longer accepting participants.
In OttawaSchizophreniaBehavioural studyAges 20–60
- Countries
- Canada
- Sponsor
- The Royal Ottawa Mental Health Centre
CompletedACTRN12608000475347
Official study titleThe NEURAPRO-E Study: A multicenter Randomized Controlled Trial (RCT) of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Symptomatic Patients at Ultra-High Risk for Early Progression to Schizophrenia and Other Psychotic Disorders to Assess the 6-month Transition Rate to First Episode Psychosis.
This study has finished and is no longer accepting participants.
In AustraliaSchizophreniaInterventional studyAges 13–40
- Countries
- Australia, Switzerland, Austria, + 5 others
- Sponsor
- Orygen, The National Centre of Excellence in Youth Mental Health
Not recruitingISRCTN57292778
This study isn't currently recruiting.
In NetherlandsSchizophreniaResearch studyAges 18–64
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen (Netherlands)
Not recruitingISRCTN17308399
This study isn't currently recruiting.
In United KingdomSchizophrenia, Depression, ...Research study
- Countries
- United Kingdom
- Sponsor
- University of Oxford (University)
